Project Grant R01HD114611
- This federal Project Grant award of $404,273 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to Virginia Commonwealth University (VCU) aims to characterize the damage that the emerging pathogen Sneathia vaginalis causes to the cellular and acellular components of the amnion, and its effect on the mechanical properties of the amnion. Through this research, the award will lay the foundation to better understand the role of...
- This Project Grant award of $126,460 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at the University of California, Davis to identify the ecological drivers of dysbiosis in the female reproductive tract. The research aims to determine how hormone-induced metabolic changes in the vaginal epithelium impact microbial communities and contribute to the development of aerobic vaginitis, an inflammatory...
- This $132,779 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research at Yale University to investigate the role of TLR7/8-activating microRNAs in fetal inflammatory response syndrome and preterm birth. The key objectives are to determine if fetal membrane/amniotic fluid-derived exosomes containing TLR7/8-activating microRNAs...
- This $145,745 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support research to investigate how the Chlamydia trachomatis bacterium modulates the host immune response and inflammasome activation. The research aims to elucidate the mechanism by which a specific Chlamydia protein, CT226, interacts with host proteins LRRFIP1 and FLII to regulate inflammasome activation during Chlamydia infection....
- This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is funding a multi-disciplinary research effort at Oregon Health & Science University (OHSU) to uncover novel insights into endocervical mucus secretion. The goal is to better understand the cells and pathways that affect changes in endocervical mucus in response to hormonal fluctuations, with the long-term...
- This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under CFDA program 93.865, "Child Health and Human Development Extramural Research," provides $430,031.00 to evaluate the role of DNA methylation changes in very early preterm birth. The grant, awarded to Harvard T.H. Chan School of Public Health, will support research activities focused on understanding the complex biological mechanisms underlying preterm birth, a critical public...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), will support research on natural killer (NK) cell recruitment and differentiation in the uterine mucosa. The $223,068 grant aims to elucidate the signals that drive the differentiation of circulating NK cells (cNK) into tissue-resident NK cells in the uterine mucosa, and investigate the function of these...
- The National Institute of Child Health and Human Development (NICHD) awarded a $424,875 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to the University of Maryland, Baltimore (UMB) to investigate the role of placental serum amyloid A (SAA) isoforms in response to sub-chronic maternal inflammation and explore whether inhibition of the SAA2 isoform using small interfering RNA (siRNA) can alleviate preterm birth and adverse fetal outcomes. The project aims...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $152,216 to the University of Pittsburgh to conduct research on anti-fungal immune responses in the female reproductive tract. The research aims to determine the cellular and molecular basis for how type 3 cytokine signaling orchestrates immune control of vulvovaginal candidiasis (VVC), a prevalent and...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will provide $148,000.00 to the University of Southern Mississippi to investigate the potential molecular mechanisms linking infertility and cancer. The primary objectives are to (1) use humanized yeast to assess the impact of 30 cancer-associated protein phosphatase 1 (PP1) variants on...
POLYAMINE MODIFICATION OF HOST IMMUNE RESPONSES AND OXIDATIVE BALANCE IN THE CERVICOVAGINAL SPACE: POTENTIAL MECHANISMS GOVERNING CERVICAL REMODELING IN PRETERM BIRTH - PROJECT SUMMARY SPECIFIC MICROBIAL AND IMMUNE FEATURES OF VAGINAL ECOSYSTEMS, INCLUDING A LACTOBACILLUS-DEPLETE MICROBIOTA, HAVE BEEN LINKED TO SPONTANEOUS PRETERM BIRTH (PTB). MECHANISMS DRIVING ASSOCIATIONS REMAIN INCOMPLETELY UNDERSTOOD. PREMATURE CERVICAL REMODELING, INVOLVING CERVICOVAGINAL (CV) EPITHELIAL BARRIER DYSFUNCTION, IS A KEY BIOLOGIC PROCESS ON THE PATHWAY TO PTB. IN OTHER SYSTEMS, METABOLOMICS HAS EMERGED AS A LENS THROUGH WHICH PHENOTYPES OF MICROBIAL ECOSYSTEMS CAN BE MORE CLEARLY ELUCIDATED. MICROBIAL AND HOST METABOLITE- MODIFICATION OF IMMUNE RESPONSES AND EPITHELIAL BARRIER INTEGRITY HAS GIVEN RISE TO NOVEL TARGETED POSTBIOTIC THERAPEUTICS. THE BIOACTIVE POTENTIAL OF THE VAGINAL METABOLOME REMAINS UNDER INVESTIGATED. OUR GROUP RECENTLY IDENTIFIED A ROLE FOR VAGINAL POLYAMINES IN DISCERNING INDIVIDUALS AT GREATEST RISK OF PTB IN THOSE WITH SIMILAR MICROBIOTA-RELATED RISK - AMONG INDIVIDUALS WITH A LACTOBACILLUS-DEPLETE MICROBIOTA, THOSE WHO DELIVERED PRETERM HAD A 25-FOLD REDUCTION IN SPERMINE. POLYAMINES SPERMIDINE AND SPERMINE PLAY KEY ROLES IN IMMUNITY AND OXIDATIVE BALANCE IN OTHER SYSTEMS. THE OVERALL GOAL OF THIS PROPOSAL IS TO ELUCIDATE THEIR EFFECTS ON BARRIER FUNCTION IN THE CV SPACE. OUR CENTRAL HYPOTHESIS IS THAT VAGINAL SPERMIDINE AND SPERMINE MAINTAIN IMMUNE HOMEOSTASIS AND MITIGATE OXIDATIVE STRESS TO ENHANCE BARRIER FUNCTION IN THE SETTING OF A LACTOBACILLUS-DEPLETE MICROBIOTA. WE FURTHER POSIT THAT INADEQUATE HOST PRODUCTION OF SPERMIDINE AND SPERMINE IN RESPONSE TO MICROBIAL CHALLENGE RESULTS IN CV BARRIER DYSFUNCTION, ASCRIBING A MECHANISTIC LINK BETWEEN VAGINAL METABOLITES AND CERVICAL REMODELING. WE PROPOSE THE FOLLOWING AIMS: 1) DETERMINE HOW POLYAMINES MODIFY IMMUNE RESPONSES IN THE CV SPACE; 2) DETERMINE HOW POLYAMINES REGULATE OXIDATIVE BALANCE IN THE CV SPACE; AND 3) QUANTIFY ASSOCIATIONS OF VAGINAL POLYAMINES WITH PREMATURE CERVICAL REMODELING. IN THE FIRST AIM, WE WILL USE IN VITRO METHODOLOGY TO INTERROGATE THE ROLE OF POLYAMINES IN INFLAMMASOME ACTIVATION, NFB-INDUCTION OF IMMUNE MEDIATORS, MACROPHAGE DIFFERENTIATION, AND EPITHELIAL-IMMUNE CELL COMMUNICATION. FOR THE SECOND AIM, WE WILL USE IN VITRO METHODOLOGY TO INVESTIGATE POLYAMINE EFFECTS ON OXIDATIVE STRESS MEASURED BY LIPID PEROXIDATION, ANTIOXIDANT ENZYME EXPRESSION, DNA AND PROTEIN DAMAGE, AS WELL AS THE ABILITY OF POLYAMINE-MEDIATED OXIDATIVE BALANCE TO MODIFY HOST IMMUNE RESPONSES. IN THE THIRD AIM, WE WILL LEVERAGE AN ONGOING PREGNANCY COHORT TO QUANTIFY ASSOCIATIONS BETWEEN POLYAMINES, LIPID PEROXIDATION MARKERS, AND SHORT CERVIX TO ASSESS THE POTENTIAL IMPACT OF POLYAMINES ON TISSUE REMODELING AND PTB. WE PROPOSE AN INNOVATIVE APPROACH TO DEFINE MECHANISMS BY WHICH THE VAGINAL METABOLOME MAY MODIFY CERVICAL REMODELING. IMPLICATIONS OF THIS WORK EXTEND BEYOND PREGNANCY, AS IMMUNE PERTURBATIONS AND OXIDATIVE STRESS CONTRIBUTE TO MYRIAD ADVERSE REPRODUCTIVE OUTCOMES. FINDINGS MAY BE HARNESSED TO MODIFY ASPECTS OF THE VAGINAL ECOSYSTEM THROUGH NOVEL POSTBIOTIC STRATEGIES, THEREBY IMPROVING REPRODUCTIVE HEALTH OUTCOMES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $652.9k | 7/21/25 | ||
| Not listed | $701.7k | 7/25/24 |